Oppenheimer Asset Management Inc. Purchases New Stake in Healthpeak Properties, Inc. (NYSE:DOC)

Oppenheimer Asset Management Inc. acquired a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 698,916 shares of the real estate investment trust’s stock, valued at approximately $15,984,000. Oppenheimer Asset Management Inc. owned 0.10% of Healthpeak Properties at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of DOC. Sumitomo Mitsui Trust Group Inc. acquired a new position in Healthpeak Properties in the 3rd quarter valued at about $102,615,000. abrdn plc bought a new stake in shares of Healthpeak Properties during the third quarter worth approximately $62,670,000. Douglas Lane & Associates LLC bought a new stake in shares of Healthpeak Properties during the third quarter worth approximately $33,947,000. Foresight Group Ltd Liability Partnership acquired a new position in shares of Healthpeak Properties in the third quarter valued at approximately $33,212,000. Finally, Victory Capital Management Inc. bought a new position in shares of Healthpeak Properties during the third quarter worth approximately $32,470,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Price Performance

Shares of DOC stock opened at $21.65 on Thursday. The business has a fifty day simple moving average of $22.30 and a 200 day simple moving average of $21.03. The company has a market cap of $15.14 billion, a P/E ratio of 46.06, a P/E/G ratio of 2.43 and a beta of 1.13. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93. Healthpeak Properties, Inc. has a twelve month low of $16.01 and a twelve month high of $23.26.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). The company had revenue of $700.40 million during the quarter, compared to the consensus estimate of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The firm’s revenue was up 25.9% compared to the same quarter last year. During the same period last year, the company posted $0.45 EPS. On average, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.8 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be issued a dividend of $0.30 per share. The ex-dividend date is Monday, November 4th. This represents a $1.20 annualized dividend and a dividend yield of 5.54%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 255.32%.

Analysts Set New Price Targets

Several research firms recently issued reports on DOC. Scotiabank boosted their price target on Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a research note on Monday, September 9th. Robert W. Baird boosted their target price on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Royal Bank of Canada raised their price target on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Wells Fargo & Company reissued an “equal weight” rating and issued a $23.00 price objective (up previously from $22.00) on shares of Healthpeak Properties in a report on Tuesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Healthpeak Properties from a “hold” rating to a “buy” rating and increased their target price for the stock from $20.00 to $28.00 in a research report on Monday, October 21st. One analyst has rated the stock with a sell rating, five have issued a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $22.86.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.